GNRH1 and leiomyoma: Ryeqo combines a gonadotropin-releasing hormone (GnRH) antagonist with hormonal add-back therapy, offering an effective alternative for controlling heavy menstrual bleeding associated with fibroids, while minimizing hypoestrogenic side effects [52].